Wall Street Set to Open Higher Friday Ahead of Consumer Sentiment, Home Sales Data
US stocks look set to open higher in Friday's trading session ahead of the University of Michigan consumer sentiment report, existing home sales data, and the weekly Baker Hughes Rig Count due to be r
U.S. Shares Higher at Close of Trade; Dow Jones Industrial Average up 0.54%
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersCelularity (NASDAQ:CELU) shares rose 43.4% to $0.27 during Thursday's pre-market session. The company's market cap stands at $52.3 million. Kronos Bio (NASDAQ:KRON) stock moved upwards by 33.64
Changes in US stocks 丨 Aravive plummeted more than 57% before the market and will be delisted from NASDAQ
GLONGHUI, January 18 | Oncology company Aravive plummeted more than 57% to $0.046 before the market. Earlier, the company announced that it would voluntarily delist from the NASDAQ Global Select Market and deregister its common stock. The NASDAQ delisting is expected to take effect around February 8.
Aravive Shares Drop 53%, Company to Delist and Deregister Stock
By Stephen Nakrosis Shares of Aravive were lower in after-hours trading following the company's announcement it would voluntarily delist its shares from the Nasdaq Global Select Market and deregister
Aravive Shares Sink 53% After Hours on Plans to Voluntarily Terminate Listing on Nasdaq Global Select Market
05:29 PM EST, 01/17/2024 (MT Newswires) -- Aravive Shares Sink 53% After Hours on Plans to Voluntarily Terminate Listing on Nasdaq Global Select Market Price: 0.05, Change: -0.06, Percent Change: -53.
Aravive Inc. Halted, News Pending
Aravive, Inc. to Delist From The Nasdaq Stock Market
HOUSTON, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Aravive, Inc. (NASDAQ:ARAV, "the Company")), announced today that the Company intends to voluntarily terminate the listing of its common stock on the Nasdaq Global Select
Trading Halt: Halted at 4:01:00 P.m. ET - Trading Halt: Halt News Pending
Trading Halt: Halted at 4:01:00 P.m. ET - Trading Halt: Halt News Pending
Aravive Filed U.S. Patent Application #20240009271: Methods Of Treating Metastatic Cancers Using AXL Decoy Receptors
Aravive Filed U.S. Patent Application #20240009271: Methods Of Treating Metastatic Cancers Using AXL Decoy Receptors
12 Health Care Stocks Moving In Friday's After-Market Session
GainersComera Life Sciences (NASDAQ:CMRA) stock increased by 11.6% to $0.28 during Friday's after-market session. The company's market cap stands at $8.5 million. The company's, Q3 earnings came out y
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersSeaStar Medical Holding (NASDAQ:ICU) shares rose 52.9% to $0.69 during Wednesday's regular session. Trading volume for SeaStar Medical Holding's stock is 114.9 million as of 13:30 EST. This is
Aravive (ARAV) Upgraded to Strong Buy: What Does It Mean for the Stock?
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersHelius Medical Tech (NASDAQ:HSDT) shares increased by 50.5% to $11.11 during Tuesday's pre-market session. The company's market cap stands at $6.2 million. Cellectar Biosciences (NASDAQ:CLRB) s
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersTrxade Health (NASDAQ:MEDS) shares moved upwards by 76.2% to $13.46 during Monday's pre-market session. The company's market cap stands at $16.7 million. Novo Integrated Sciences (NASDAQ:NVOS)
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersTrxade Health (NASDAQ:MEDS) stock moved upwards by 99.2% to $15.22 during Friday's pre-market session. The market value of their outstanding shares is at $18.9 million. Novo Integrated Sciences
AMC, MMLP and ARAV Among Mid-day Movers
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersNanoVibronix (NASDAQ:NAOV) stock increased by 71.0% to $2.48 during Wednesday's pre-market session. The company's market cap stands at $4.1 million. Aravive (NASDAQ:ARAV) stock moved upwards by
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersNemaura Medical (NASDAQ:NMRD) shares increased by 36.6% to $0.56 during Thursday's regular session. Nemaura Medical's stock is trading at a volume of 2.0 million shares as of 13:30 EST. This is
[BT Agency Stock Review] Biotech company Aravive's stock rating downgraded
Following the release of second-quarter earnings, Cantor Fitzgerald downgraded biotech company Aravive's rating from “overbearing” to “neutral,” and lowered its target price from $18 to 25 cents. The bank said it would end the phase 1b/ 2 clinical trial of batiraxcept unless more funding was raised.
No Data